Wealthspire Advisors (New York)’s ARK Genomic Revolution ETF ARKG Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-2,363	Closed	-$219K	–	580
2021 Q2	$219K	Sell	2,363 -664	-22%	-$61.5K	0.01%	342
2021 Q1	$269K	Buy	+3,027	New	+$269K	0.01%	583